Home/Filings/4/0001415889-24-019162
4//SEC Filing

JOHNSON DAVID LEE 4

Accession 0001415889-24-019162

CIK 0001831828other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:05 PM ET

Size

5.5 KB

Accession

0001415889-24-019162

Insider Transaction Report

Form 4
Period: 2024-07-01
JOHNSON DAVID LEE
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-07-01+160,000160,000 total
    Exercise: $36.29Exp: 2034-06-30Class A Common Stock (160,000 underlying)
Footnotes (1)
  • [F1]1/4 of the shares subject to the option vest on July 1, 2025, and 1/48 of the shares vest monthly thereafter, subject to continuous service of the Reporting Person through each vesting date.

Issuer

Vera Therapeutics, Inc.

CIK 0001831828

Entity typeother

Related Parties

1
  • filerCIK 0001733883

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:05 PM ET
Size
5.5 KB